Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Certified Reference Material produced under an ISO 17034 accredited process.
Certificates of Analysis are available electronically at www.atcc.org, or by hardcopy upon request.
The cells are reported to contain an integrated human papillomavirus type 16 genome (HPV-16, about 600 copies per cell) as well as sequences related to HPV-18.
NOTE: Virology taxonomy has discontinued use of the family name "Papovaviridae," which includes the term "Papovavirus." Instead, this former family name, "Papovaviridae," has now been split into two distinct and separate families, "Papillomaviridae" and "Polyomaviridae." As such, all cultures containing HPV should be noted to contain "Papillomavirus" (signifying it's origin from the "Papillomaviridae" family) instead of the former "Papovavirus."
Pattillo RA, et al. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196: 1456-1458, 1977. PubMed: 867042
Baker CC, et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61: 962-971, 1987. PubMed: 3029430
Pater MM, Pater A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145: 313-318, 1985. PubMed: 2992153
Yee C, et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119: 361-366, 1985. PubMed: 2990217
Hendricks DT, et al. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res. 57: 2112-2115, 1997. PubMed: 9187105
